Rheumatology faces significant infection-related challenges, especially with the use of immunosuppressants and biological therapies, which have revolutionized treatment but raise concerns about infections in immunocompromised patients. This SIG aims to create a focused forum for clinical, educational, and research purposes. The goals of the SIG are to provide a platform for those interested in rheumatology-related infections, offer rheumatologists opportunities to expand their knowledge and stay updated on the latest developments, establish connections with national experts in microbiology, infectious diseases, orthopedics, musculoskeletal radiology, and nuclear medicine, promote collaborative research, and support the development of clinical guidelines through collaboration with biologics registers.